共 31 条
[1]
Hirsch M.S., D' Aquila R.T., Therapy for human immunodeficiency virus infection, N Engl J Med, 328, (1993)
[2]
Sande M.A., Carpenter C., Cobbs C.G., Holmes K.K., Sanfrod J.P., Antiretroviral therapy for adult hiv-infected patients: Recommendations from a state-of-the-art conference, JAMA, 270, pp. 2583-2589, (1993)
[3]
Richman D.D., Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents, Antimicrob Agents Chemother, 37, pp. 1207-1213, (1993)
[4]
Erice A., Balfour H.H., Resistance of human immunodeficiency virus type 1 to antiretroviral agents: A review, Clin Infect Dis, 18, pp. 149-156, (1994)
[5]
Tudor-Williams G., St Clair M.H., Mc Kinney R.E., Et al., Hiv-1 sensitivity to zidovudine and clinical outcome in children, Lancet, 339, pp. 15-19, (1992)
[6]
Kozal M.J., Shafer R.W., Winters M.A., Katzenstein D.A., Merigan T.C., A mutation in human immunodeficiency virus reverse transcriptase and decline in cd4 lymphocyte numbers in long-term zidovudine recipients, J Infect Dis, 167, pp. 526-532, (1993)
[7]
Montaner J., Singer J., Schecter M.T., Et al., Clinical correlates of in vitro hiv-1 resistance to zidovudine. Results of the multicenter canadian azt trial, AIDS, 7, pp. 189-196, (1993)
[8]
Ogino M.T., Dankner W.M., Spector S.A., Development and significance of zidovudine resistance in children infected with human immunodeficiency virus, J Pediatr, 123, pp. 1-8, (1993)
[9]
St Clair M.H., Martin J.L., Tudor-Williams G., Et al., Resistance to ddl and sensitivity to azt induced by a mutation in hiv-1 reverse transcriptase, Science, 253, pp. 1557-1559, (1991)
[10]
Larder B.A., 3'-azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnuclcoside reverse transcriptase inhibitors, Antimicrob Agents Chemother, 36, pp. 2664-2669, (1992)